Keywords: telbivudine, performs, well, hep, trial, swiss, drug

Telbivudine performs well in hep B trial

Article | 03 April 2006

Print This

Swiss drug major Novartis says that the results of a Chinese Phase III trial of its developmental nucleoside analog telbivudine, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in